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The balance between the breakdown and synthesis of extra-
cellular matrix is crucial for the integrity of the structure 
and function of articular cartilage. This homeostasis is 
maintained by catabolic and anabolic processes that are 
regulated by chondrocytes and other cells in articular joints. 
Interleukin (IL)-1β was found to be involved in disturbed 
homeostasis, mainly due to increased expression and activ-
ity of matrix metalloproteinases (MMPs), leading to carti-
lage degeneration.1,2 One of the major regulators of catabolic 
processes induced by IL1β is the nuclear factor (NF)-κB 
signaling pathway.3,4 In the absence of an inflammatory sig-
nal, the p50 and p65 subunits form an inactive heterotrimer 
with IκBα, which resides in the cytoplasm. After activation 
of the pathway, IκBα is removed from the complex and p50 
and p65 translocate to the nucleus to regulate gene tran-
scription through NFκB binding sites in promoters of target 
genes.5 The NFκB pathway was found to be essential for the 
expression of MMP1, MMP3, MMP13, and IL6, IL1β, and 
tumor necrosis factor (TNF)-α. In addition, inflammatory 
activation of the NFκB pathway can induce hypertrophic 
differentiation, which is involved in cartilage degenerative 
disease.6
Recently, WNT/β-catenin signaling was found in IL1β-
induced cartilage degradation.7-9 In absence of a WNT 
ligand, β-catenin is phosphorylated by a degradation com-
plex and subsequently degraded by the proteasome. On 
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Abstract
Objective: Previous studies indicated a difference in crosstalk between canonical WNT pathway and nuclear factor-κB 
(NFκB) signaling in human and animal chondrocytes. To assess whether the differences found were dependent on cell 
types used, we tested the effect of WNT modulation on NFκB signaling in human primary articular chondrocytes in 
comparison with the immortalized human costal chondrocyte cell line C20/A4. Design: We used gene expression analysis 
to study the effect of WNT modulation on IL1β-induced matrix metalloproteinase (MMP) expression as well as on WNT 
and NFκB target gene expression. In addition, we tested the involvement of RelA and TCF4 on activation of the WNT and 
NFκB pathway by TCF/LEF and NFκB reporter experiments, respectively. Results: We found an inhibitory effect of both 
induction and inhibition of WNT signaling on IL1β-induced MMP mRNA expression in primary chondrocytes, whereas 
WNT modulation did not affect MMP expression in C20/A4 cells. Furthermore, TCF/LEF and NFκB reporter activation 
and WNT and NFκB target gene expression were regulated differentially by TCF4 and RelA in a cell type–dependent 
manner. Additionally, we found significantly higher mRNA and protein expression of TCF4 and RelA in C20/A4 cells in 
comparison with primary chondrocytes. Conclusions: We conclude that WNT modulation of NFκB is, at least in part, cell 
type dependent and that the observed differences are likely because of impaired sensitivity of the NFκB pathway in C20/
A4 cells to modulations in WNT signaling. This might be caused by higher basal levels of TCF4 and RelA in C20/A4 cells 
compared to primary chondrocytes.
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binding of a WNT ligand to the receptor Frizzled (FZD) and 
its co-receptors low-density lipoprotein receptor–related 
protein (LRP) 5/6, the degradation complex is disassem-
bled, resulting in accumulation of β-catenin in the cyto-
plasm. Subsequently, β-catenin can translocate to the 
nucleus to bind T-cell specific factor (TCF)-4 and 
lymphoid-enhancer factor (LEF)-1, thereby regulating gene 
expression.10 Our group has recently shown that in human 
chondrocytes, canonical WNT signaling is a potent inhibi-
tor of pro-inflammatory mediator-induced MMP expression 
by counteracting pro-catabolic NFκB. The inhibitory action 
of WNT signaling was found to be due to direct interaction 
of β-catenin with the NFκB pathway,8 found in various can-
cer cells.11,12 More specifically, it was shown that β-catenin 
interacted with RELA.11 These observations indicated that 
β-catenin has an anti-catabolic effect by inhibiting MMP 
expression in human cartilage, whereas a pro-catabolic role 
of β-catenin in animal cartilage was reported.7,13 However, 
β-catenin interacted with the NFκB pathway and inhibited 
NFκB-mediated signaling in mouse cells, suggesting that 
β-catenin–RELA interaction is not responsible for the 
species-specific effect of WNT signaling on MMP expres-
sion.8 In contrast to human chondrocytes, induction of 
MMP expression by IL1β in animal chondrocytes was 
dependent on β-catenin.8 In addition, our group has shown 
that overexpression of TCF4 in human chondrocytes, 
expressed higher in human osteoarthritic cartilage, induced 
the expression and activity of MMPs in human chondro-
cytes.14 Furthermore, induction of MMP expression by 
TCF4 appeared to be due to the potentiating effect of TCF4 
on NFκB signaling likely by direct interaction with RELA.14
The dissimilarity in the interaction between the WNT 
pathway and NFκB signaling was attributed to a species-
specific effect.8 To verify whether this effect was rather 
caused by differences in the cellular environment, we 
assessed the effects of induction and inhibition of WNT/β-
catenin signaling on NFκB and related MMP expression in 
human primary articular chondrocytes (hCh) and the 
immortalized human costal chondrocyte cell line C20/A4. 
We found active crosstalk between the WNT pathway and 
NFκB signaling in hCh, which was partial or absent in C20/
A4, indicating a cell-specific interaction between WNT and 
NFκB.
Methods
Cell Isolation and Culture
Human primary articular chondrocytes were isolated from 
healthy looking cartilage of the femoral condyles of patients 
undergoing total knee replacement surgery. Isolated carti-
lage was digested with collagenase type II at 37°C over-
night and cells were isolated using a 100-µm cell strainer. 
Isolated hCh were cultured as previously described15 and 
used at passage 2. Immortalized human juvenile costal 
chondrocytes, C20/A4 cells,16 were cultured in Dulbecco’s 
modified Eagle’s medium supplemented with 10% fetal 
bovine serum, 100 U/mL penicillin, and 100 mg/mL strep-
tomycin. The use of human biopsies was approved by the 
local ethical committee and all patients gave their consent 
for the use of their tissues.
Viral Transduction Assays
Human primary articular chondrocytes and C20/A4 were 
seeded at 7500 cells/cm2 in 96-well plates (Nunc 
International) and cultured for 24 hours, prior to transfec-
tion with lentiviral TCF/LEF reporter and pRL-CMV con-
trol (both Promega, Madison, WI). Cells were treated with 
200 ng/mL recombinant human WNT3A (high purity, 
R&D Systems, Minneapolis, MN), 1.0 µM GSK3β inhibi-
tor BIO (Sigma Aldrich, St. Louis, MO) or 1.0 µM PKF115-
584 (Novartis, Basel, Switzerland), a small molecule 
blocking binding of β-catenin to transcription factor 
TCF4.17 All treatments were performed with or without 
addition of 10 ng/mL IL1β (R&D Systems, Minneapolis, 
MN). After 48 hours of stimulation, luminescence was 
measured using the Dual-Glo luciferase assay kit (Promega, 
Madison, WI).
Gene Expression Analysis
Human primary articular chondrocytes and C20/A4 were 
seeded at 25,000 cells/cm2 in 24-well plates (Nunc 
International, Rochester, NY) and cultured for 24 hours 
before addition of 200 ng/mL recombinant human 
WNT3A (high purity, R&D Systems), 1.0 µM GSK3β 
inhibitor BIO or 1.0 µM PKF115-584 with or without 
addition of 10 ng/mL IL1β (R&D Systems). Forty-eight 
hours later, cells were harvested and analyzed as previ-
ously described.15 Gene expression was normalized using 
B2M and expressed as fold induction compared with 
controls.
Western Blot
For Western blot analysis, cells were lysed using RIPA buf-
fer (Cell Signaling Technology, Danvers, MA), supple-
mented with Halt protease and phosphatase inhibitor 
cocktail (Thermo Scientific, Waltham, MA). Antibodies 
used for Western blot were mouse anti-human β-catenin 
(1:1000, BD Biosciences, Franklin Lakes, NJ), rabbit anti-
human NFκB p65 (RELA, 1:1000, Santa Cruz 
Biotechnology, Santa Cruz, CA), mouse anti-human TCF4 
(1:1000, Cell Signaling), and rabbit anti-mouse and goat 
anti-rabbit secondary antibodies (1:1000, Invitrogen, 
Carlsbad, CA). SuperSignal West Femto Substrate (Thermo 
Scientific) was used for visualization of the bands.
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Statistical Analysis
Results were expressed as mean values ± 95% confidence 
intervals (CIs) and statistical significance was tested using 
analysis of variance for multiple conditions or Student’s t 
test for comparing 2 conditions (PASW Statistics 18).
Results
The Effect of WNT Signaling on mRNA 
Expression of MMPs Is Cell Type Dependent
Since basal MMP expression is relatively low in chondrocytes, 
cells were treated with IL1β to induce gene expression. This 
enabled us to study the effect of induction and inhibition of 
canonical WNT signaling on MMP expression. In basal condi-
tions in hCh, neither WNT3A and BIO nor PKF115-584 
affected MMP expression. IL1β potently induced MMP1, 
MMP3, and MMP13 expression. Interestingly, both activation 
of canonical WNT signaling by treatment with WNT3A and 
BIO, as well as inhibition of canonical WNT signaling by 
PKF115-584, inhibited IL1β-induced MMP1 expression. In 
C20/A4, MMP1 expression was not significantly affected by 
activation or inhibition of WNT signaling, neither in basal con-
ditions nor after IL1β induction (Fig. 1A). The mRNA expres-
sion of MMP3 in hCh was significantly inhibited by BIO, 
whereas the expression was not significantly changed by 
WNT3A and PKF115-584. In contrast, in C20/A4, IL1β-
induced MMP3 expression was slightly enhanced by co-treat-
ment with WNT3A and BIO, whereas PKF115-584 inhibited 
MMP3 expression (Fig. 1B). In hCh, WNT3A and PKF115-
584 repressed IL1β-induced MMP13 expression, whereas BIO 
did not significantly affect MMP13 expression. The expression 
of MMP13 was inhibited by WNT3A, BIO, and PKF115-584, 
although not significantly changed by WNT3A in C20/A4 
(Fig. 1C). The effect of inhibition of WNT/β-catenin signaling 
by PKF115-584 is similar in hCh and C20/A4. However, the 
inhibitory effect of WNT3A and BIO on MMP3 expression in 
hCh is opposite to the stimulating effect in C20/A4. The dis-
similarity of WNT3A, which acts at the receptor level, was not 
Figure 1. Distinct effects of WNT modulation in human primary articular chondrocytes (hCh) and C20/A4. (A) IL1β (10 ng/mL) 
induced expression of MMP1 was inhibited by co-treatment with WNT3A (200 ng/mL) and BIO (1.0 µM) as well as with PKF115-
584 (1.0 µM) in hCh, whereas in C20/A4, MMP1 expression was not affected by any of the compounds. (B) IL1β-induced MMP3 
expression was only inhibited by BIO in hCh and by PKF115-584 in C20/A4. (C) The mRNA expression of MMP13 was inhibited 
by WNT3A and PKF115-584 in hCh, whereas in C20/A4, both BIO and PKF115-584 blocked IL1β-induced MMP13 expression. 
Expression levels were determined by qPCR after normalization for a house hold gene. Graphs are representative for 3 independent 
experiments and expressed as fold induction compared with controls ± 95% confidence interval.
184 Cartilage 5(3)
as pronounced as the opposing effect of BIO, which acts more 
downstream in the WNT/β-catenin pathway.
These findings indicate a cell type dependent effect of 
modulation of the WNT signaling pathway on cytokine-
induced MMP mRNA expression, which might be regulated 
by β-catenin or at the transcriptional level. Therefore, we 
tested the involvement of downstream WNT effectors 
β-catenin and TCF4 and the NFκB mediator RELA on TCF/
LEF and NFκB-promoter reporter constructs.
TCF4 Enhances IL1β-Induced NFκB Reporter 
Activity in hCh but Not in C20/A4
To test the involvement of the NFκB signaling mediator 
RELA in the WNT pathway, cells were co-transduced with 
a TCF/LEF reporter construct and a short hairpin (sh) RNA 
construct for RELA. In hCh, WNT3A and BIO induced 
TCF/LEF reporter activity, whereas the TCF/β-catenin 
inhibitor PKF115-584 did not affect the TCF/LEF reporter. 
The upregulation of the TCF/LEF reporter by WNT3A and 
BIO was slightly enhanced by the knockdown of RELA, 
while co-treatment with IL1β inhibited reporter activation 
by BIO. In C20/A4, WNT3A and BIO activated the TCF/
LEF reporter, whereas reporter activity was not affected by 
addition of IL1β. Knockdown of RELA inhibited BIO-
induced upregulation of TCF/LEF reporter activity 
(Fig. 2A). This suggests that TCF/LEF reporter activation 
by BIO is at least partly dependent on RELA.
To study the involvement of TCF4 in the activation of the 
NFκB pathway, TCF4 was adenovirally overexpressed in cells 
Figure 2. Overexpression of TCF4 enhances IL1β induction of NFκB reporter activity in human primary articular chondrocytes 
(hCh), but blocks IL1β-induced NFκB activity in C20/A4. (A) TCF/LEF reporter activity in hCh is upregulated by both WNT3A and 
BIO, which is slightly enhanced by knockdown of RELA. IL1β inhibits the induction of TCF/LEF reporter by BIO. In C20/A4, TCF/LEF 
reporter activity is induced by WNT3A and BIO and slightly inhibited by knockdown of RELA. (B) NFκB reporter activity is induced 
by IL1β in hCh and enhanced by WNT3A and BIO. Overexpression of TCF4 induces NFκB reporter activity in hCh. In addition, in 
C20/A4 NFκB reporter activity is induced by IL1β, which is inhibited by overexpression of TCF4. (C) Western blot analysis confirms 
partial downregulation of RELA protein expression by shRELA and upregulation of TCF4 by AdTCF4. Data is representative for 3 
independent experiments and expressed as fold induction compared with control ± 95% confidence interval.
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that were transduced with the NFκB promoter reporter con-
struct. NFκB reporter activity was significantly induced by IL1β 
by 2.6 fold (P = 0.03), which was enhanced by both WNT3A 
and BIO in hCh. Additionally, overexpression of TCF4 strongly 
induced NFκB reporter activity, which was further enhanced by 
co-treatment with BIO. In C20/A4, the NFκB reporter was 
strongly induced by IL1β by 7.9 fold (P = 0.01), without signifi-
cant effects of WNT3A, BIO, or PKF115-584. Interestingly, 
IL1β-induced NFκB reporter activity was inhibited by overex-
pression of TCF4 (Fig. 2B). This suggests that TCF4 is induc-
tive for NFκB reporter activity in hCh, but inhibitory in C20/A4.
The knockdown of RELA by shRELA and the overex-
pression of TCF4 by AdTCF4 were confirmed by Western 
blot analysis (Fig. 2C).
Target Gene Expression Is Affected by WNT 
Modulation in a Cell Type–Specific Manner
To verify whether the WNT signaling pathway is equally 
active in hCh and C20/A4, we assessed the effects on AXIN2 
mRNA expression. In both hCh and in C20/A4, AXIN2 
mRNA expression was induced by WNT3A and BIO, how-
ever, BIO was more potent in C20/A4 than in hCh. As 
expected, PKF115-584 did not affect AXIN2 expression. 
Co-treatment with IL1β did not significantly affect AXIN2 
expression in hCh and C20/A4, but was significantly 
reduced in BIO treated C20/A4 cells (Fig. 3A).
We next examined the effect on the established NFκB 
target gene SERPINA1. The upregulation of SERPINA1 by 
IL1β was much stronger in C20/A4, when compared to 
hCh. IL1β induced SERPINA1 expression was not signifi-
cantly changed by BIO and PKF115-584 in hCh. In C20/
A4, WNT3A and PKF115-584 inhibited SERPINA1 expres-
sion, whereas BIO upregulated IL1β induced SERPINA1 
mRNA expression (Fig. 3B).
The effect of IL1β stimulation as well as the influence of 
WNT modulation was much stronger in C20/A4 compared 
with hCh. Since RELA and its interaction with TCF4 seem 
to be involved in IL1β-induced activity, we next assessed 
the expression levels of these mediators.
Figure 3. (A) In hCh, AXIN2 expression was upregulated by both WNT3A and BIO, whereas PKF115-584 did not affect AXIN2 
expression. Addition of IL1β slightly inhibited upregulation of AXIN2 expression by WNT3A and BIO. In C20/A4, AXIN2 expression 
was induced by WNT3A and BIO, which was not significantly affected by IL1β. PKF115-584 did not affect AXIN2 expression. (B) 
SERPINA1 expression was induced by IL1β in both hCh and C20/A4. Upregulation was inhibited by BIO and PKF115-584 in hCh, but 
differences were not significant. However, in C20/A4, IL1β induced SERPINA1 expression was slightly enhanced by BIO, whereas 
WNT3A (not significant) and PKF115-584 inhibited IL1β-induced SERPINA1 expression. Expression levels were determined by 
quantitative polymerase chain reaction (qPCR) after normalization for a house hold gene. Data are representative for 3 independent 
experiments and expressed as fold induction compared with control ± 95% confidence interval.
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Primary Chondrocytes Express Lower Levels of 
TCF4 and RelA Compared To C20/A4
We did not find significant differences in mRNA expression 
of TCF4, β-catenin, or RELA between hCh and C20/A4. 
Even though the mRNA expression of TCF4 seemed lower 
in C20/A4, protein levels were higher than in hCh (Fig. 
4A). Both mRNA and protein expression of β-catenin were 
higher in C20/A4 when compared to hCh (Fig. 4B). As for 
RELA, mRNA expression was reduced in C20/A4 cells in 
comparison with hCh, whereas protein levels were higher in 
C20/A4 compared to hCh (Fig. 4C).
Finally, we studied the expression of several Frizzled 
receptors, in hCh from healthy looking and arthritic regions 
of the joint and C20/A4. We found significantly higher 
expression of FRZ2, FRZ4, FRZ5, FRZ6, and FRZ7 in C20/
A4 when compared to hCh (Fig. 4D). No differential 
expression of Frizzled receptors was found between hCh 
from healthy looking regions and arthritic regions from the 
same joint.
Discussion
Previously, our group reported the inhibitory effect of 
β-catenin on MMP expression in human chondrocytes by 
counteracting NFκB signaling.8 This was in contrast to the 
observation that WNT/β-catenin signaling had a pro- 
catabolic effect by mediating NFκB-induced MMP expres-
sion in mouse chondrocytes.7,13 These results suggested dif-
ferential crosstalk between signaling pathways involved in 
regulation of MMP expression in chondrocytes. However, 
β-catenin was found to inhibit NFκB signaling in colon and 
Figure 4. (A) Human primary articular chondrocytes (hCh) expressed significantly lower mRNA and protein levels of TCF4 
compared with C20/A4 under basal conditions. (B) Slightly higher protein expression of β-catenin was found in C20/A4, compared 
with hCh. (C) No significant difference was found in mRNA expression of RELA between hCh and C20/A4, whereas protein 
expression was significantly higher in C20/A4. (D) FRZD2, FRZD4, FRZD5, FRZD6 and FRZD7 were significantly higher expressed in 
C20/A4 when compared to hCh. No differential expression was found between hCh from healthy looking regions (HL) and arthritic 
regions (OA) from the same joint. Gene expression levels were determined by qPCR after normalization for a house hold gene. Data 
are expressed as the mean of 3 independent experiments ± 95% confidence interval.
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breast tumors in mice11 and overexpression of β-catenin 
blocked NFκB signaling in various colon and liver cancer 
cells.12 The discrepancy in the effect of β-catenin on NFκB-
induced MMP expression between mouse chondrocytes and 
mouse cancer cells, suggests a differential role that is cell 
type specific rather than species specific. These findings 
indicate that the crosstalk between the WNT/β-catenin 
pathway and NFκB signaling might be dependent on intra-
cellular and/or extracellular environment.
In this study, we provide evidence that the crosstalk 
between WNT signaling and NFκB might be cell type 
dependent in human as well. We found differential effects 
of WNT induction by recombinant WNT3A or the GSK3β 
inhibitor BIO and WNT inhibition by PKF115-584 on 
IL1β-induced MMP expression between hCh and C20/A4. 
These results are in line with previous findings on the role 
of WNT/β-catenin signaling in IL1β-induced MMP expres-
sion.18,19 The consistent effect of induction as well as inhibi-
tion of WNT signaling to block IL1β-induced MMP 
expression might be due to TCF4-mediated upregulation of 
MMP expression through interaction with the NFκB path-
way by binding RELA/p65.14 WNT3A and BIO are both 
inducers of the WNT/β-catenin signaling pathway, resulting 
in high levels of β-catenin, which translocates to the nucleus 
to bind TCF4. As a result, TCF4 is no longer available to 
interact with the NFκB pathway. The inhibitory effect of the 
WNT/β-catenin inhibitor PKF115-584 might be because of 
its established disturbing action on the binding of β-catenin 
to TCF4. Similarly, PKF115-584 may also block the bind-
ing of TCF4 to RELA.17,20 Stimulation of the WNT pathway 
by WNT3A and BIO might result in higher cytoplasmic lev-
els of β-catenin, which inhibits NFκB signaling by binding 
RELA in chondrocytes and other cell types.8,11,12 Moreover, 
PKF115-584 can exert the same effect by blocking the bind-
ing of β-catenin to TCF4, resulting in more β-catenin to be 
available for binding RELA. In addition, the different 
approaches of these activators might induce differential 
interaction with NFκB signaling. PKF115-584 might pro-
hibit interaction of β-catenin with NFκB mediators by 
blocking the epitopes that are responsible for these 
interactions.
In hCh, knockdown of RELA induced TCF/LEF reporter 
activity by BIO. This is in line with the inhibitory effect of 
overexpression of RELA on β-catenin-mediated transcrip-
tion, as described previously.21 In contrast, reporter activity 
was inhibited in the absence of RELA in C20/A4. 
Additionally, the NFκB reporter in hCh is activated by 
overexpression of TCF4, in line with previous findings.8 In 
contrast, we found a stimulating effect on NFκB reporter 
activity by BIO. This effect cannot be explained by the 
increased cytoplasmic levels of β-catenin, which might be 
available for binding RELA and subsequently blocking 
NFκB signaling.11,12 In contrast to our findings in hCh, 
overexpression of TCF4 inhibited IL1β-induced NFκB 
reporter activation in C20/A4, indicating differential inter-
ference of RELA and TCF4 with the WNT pathway and 
NFκB signaling between cell types.
The inhibition of IL1β-induced SERPINA1 mRNA 
expression by BIO and PKF115-584 in hCh and by PKF115-
584 in C20/A4, provides further evidence for inhibition of 
MMP expression by WNT modulation through blocking of 
the NFκB signaling pathway. In C20/A4, PKF115-584 
affected SERPINA1 expression in accordance with the 
inhibitory effect on MMP expression. Stimulation of WNT 
signaling by WNT3A and BIO did not consistently affect 
NFκB signaling and/or its effect on MMP expression in 
C20/A4.
In search for clarification of discrepancies between hCh 
and C20/A4, we assessed the mRNA and protein expression 
of the major mediators in the WNT and NFκB signaling 
pathways. The higher protein expression of TCF4 in C20/
A4 as compared to hCh indicates the insensitivity of C20/
A4 to modulation of TCF4 by compounds or adenoviral 
overexpression of TCF4. Higher basal levels of TCF4 might 
lower the cells responsiveness to small changes, as shown 
in cancer cells in which NFκB signaling is constitutively 
active.22 Lower sensitivity of the cells to changes in NFκB 
activity might be responsible for the small NFκB response 
of the C20/A4 to WNT modulation, as compared with the 
response of hCh to WNT modulation. Furthermore, higher 
protein expression of RELA in C20/A4 compared with hCh 
could cause the more abundant response on IL1β-induced 
NFκB reporter activity.
We found higher mRNA expression of FRZ2, FRZ4, 
FRZ5, FRZ6, and FRZ7 in C20/A4, compared to hCh. Even 
though it is unknown which WNT ligands interact with 
these receptors, Frizzled5, Frizzled6 and Frizzled7 were 
identified as activators of canonical WNT/β-catenin signal-
ing.23-25 The differing receptor expression profiles may 
explain differences in biological responses on stimulation 
by WNT ligands. Differences in intracellular components 
of the WNT and NFκB signaling pathways may further con-
tribute to the observed differences between hCh and the 
C20/A4 cell line.
It has been described that chondrocytes cultured in 
monolayers do not behave similarly to chondrocytes in their 
natural environment.26,27 Chondrocytes dedifferentiate 
when cultured in monolayers and alter their gene expres-
sion profile.28 Extending these findings to the immortalized 
cell line C20/A4 indicates that these cells might have dedif-
ferentiated more than the primary chondrocytes used in this 
study. This could explain the differences that were found. In 
addition, these cells might resemble primary chondrocytes 
more when cultured in micromasses, as was found for the 
immortalized chondrocyte cell line C28/I2.29 Micromass 
culture changes the microenvironment of the cells, and 
might therefore alter the differences between hCh and C20/
A4 that we found in this study.
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In conclusion, our findings indicate that distinct effects 
of WNT modulation on IL1β-induced MMP expression in 
hCh and C20/A4 might be caused by impaired sensitivity of 
C20/A4 to changes in NFκB signaling resulting from differ-
ences in basal expression of major mediators of the WNT 
pathway and NFκB signaling. Since we used primary artic-
ular chondrocytes and immortalized costal chondrocytes, 
dissimilarities found, might be due either to location of the 
body where these cells were derived from or different cir-
cumstances in which they were maintained. Either way, dif-
ferences in responses are considered cell type specific. 
Therefore, precautions have to be taken when extending 
results on molecular interaction between WNT and NFκB 
signaling from cell lines, to primary chondrocytes. Based 
on this study, we conclude that the difference between ani-
mal and human chondrocytes in effects of WNT/β-catenin 
signaling on IL1β-induced MMP expression are likely 
caused by environmental factors like expression of key 
components in either signaling pathway rather than true 
species differences.
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